Human Formulations

Deflazacort 12 mg Film-Coated Tablet

Deflazacort 12 mg Film-Coated Tablet is a film-coated tablet formulated with 12 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immun

TabletsNon-Beta-Lactam Tablets Single Ingredient Film-Coated Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Tablets, Non-Beta-Lactam Tablets
Dosage Form
Film-Coated Tablet
Product Type
Single Ingredient

Available strengths

12 mg

Description

Deflazacort 12 mg Film-Coated Tablet is a film-coated tablet formulated with 12 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immunosuppressive activity and requires clinician-directed use. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured